Viewing Study NCT07045558


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-28 @ 3:42 AM
Study NCT ID: NCT07045558
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-01
First Post: 2025-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
Sponsor: RenJi Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable Hepatocellular Carcinoma View
Keywords: